Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Timing your insulin could change how your body stores fat

NCT ID NCT07172672

Knowledge-focused Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether the timing of insulin doses with meals affects where fat is stored in the body for people with type 1 diabetes. Ten participants will drink a high-fat liquid meal and receive insulin at different times (before, during, after, or skipping the dose). Researchers will use PET scans to track fat storage in organs like the liver and muscles. The goal is to understand if delaying insulin leads to more unhealthy fat storage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
meal insulin timing (timing of insulin bolus)
What this could lead to
If successful, this could help people with type 1 diabetes better manage fat storage and metabolic health by optimizing when they take insulin with meals.
What could go wrong
This is a very small (10 people), early-stage study that only looks at short-term fat storage after a single meal. Results may not apply to real-life eating patterns or long-term health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2025

An estimate. Start dates often move.

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Type 1 diabetes duration \> 3 years or c-peptide negative * Written and informed consent Exclusion Criteria: * Medicine with an impact on blood glucose or blood pressure * Affected screening blood sample as evaluated by the clinical responsible investigator. * Alcohol or substance abuse * BMI \> 35 kg/m2 or \< 18.5 kg/m2 * Participation in other clinical trials involving ionized radiation within the last 6 months * Lactose intolerance * Doesn't speak and understand Danish. * Severe claustrophobia. * Commitment to special diets

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postprandial lipid metabolism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Insulin Resistance type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postprandial lipid metabolism Type 1 diabetes (T1D)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Nuclear Medicine & PET-Centre, AUH Palle Juul-Jensens Blvd. 165, 8200 Aarhus N, Denmark and Medical Research Laboratories/Steno Diabetes Center Aarhus, AUH Palle Juul-Jensens Blvd. 11, 8200 Aarhus N, Denmark

    Aarhus, 8200, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.